SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report) was the target of some unusual options trading activity on Thursday. Stock traders bought 57,758 call options on the company. This represents an increase of approximately 47% compared to the typical volume of 39,379 call options.
Institutional Investors Weigh In On SPDR S&P Biotech ETF
Institutional investors have recently added to or reduced their stakes in the stock. Axiom Investment Management LLC acquired a new position in shares of SPDR S&P Biotech ETF during the first quarter worth about $26,000. Financial Life Planners acquired a new position in SPDR S&P Biotech ETF during the 1st quarter worth approximately $27,000. Angeles Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $28,000. SHP Wealth Management bought a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth $31,000. Finally, Morling Financial Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the second quarter worth $36,000.
SPDR S&P Biotech ETF Stock Performance
XBI stock traded up $2.92 during midday trading on Thursday, hitting $149.69. 6,829,601 shares of the company’s stock were exchanged, compared to its average volume of 9,148,860. SPDR S&P Biotech ETF has a one year low of $106.30 and a one year high of $169.89. The stock’s fifty day moving average price is $158.45 and its 200-day moving average price is $146.68. The company has a market cap of $10.03 billion, a PE ratio of 11.47 and a beta of 0.83.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
- Fastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure
- Synopsys Signals Confidence With $1B Accelerated Buyback, Analysts Raise Targets
- Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But Up
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
